SNORD114-14: A Potential Drug Target Or Biomarker (G767592)

Target Name: SNORD114-14

NCBI ID: G767592

SNORD114-14

Other Name(s): 14q(II-14) | Small nucleolar RNA, C/D box 114-14 | small nucleolar RNA, C/D box 114-14

SNORD114-14: A Potential Drug Target Or Biomarker

SNORD114-14 (14q(II-14)) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker in various diseases, including cancer. Its unique structure and function make it an intriguing target for researchers to investigate.

The 14q region of the chromosome is a highly conserved region that is found in all human chromosomes. It is also home to several genees that have been implicated in various diseases, including cancer. The SNORD114 gene is a non-coding RNA molecule that is located on the 14th chromosome, specifically on the II chromosome.

SNORD114-14 is a small RNA molecule that has a length of approximately 240 nucleotides. Its unique feature is its ability to interact with specific protein molecules, which allows it to play a critical role in various cellular processes.

One of the most significant functions of SNORD114-14 is its ability to interact with the protein encoded by the CDKN2A gene. CDKN2A is a tumor suppressor gene that has been implicated in various diseases, including cancer. SNORD114-14 has been shown to interact with CDKN2A and can inhibit its activity, leading to the suppression of cancer cell growth.

Another function of SNORD114-14 is its ability to interact with the protein encoded by the NF1 gene. NF1 is a gene that has been implicated in various diseases, including neurofibromatosis, a genetic disorder that causes tumors and other neurological problems. SNORD114-14 has been shown to interact with NF1 and can inhibit its activity, leading to the suppression of cancer cell growth.

In addition to its functions in inhibiting the activity of CDKN2A and NF1, SNORD114-14 has also been shown to play a role in regulating the expression of various genes in the body. This is achieved through its interaction with specific RNA molecules, which allows it to either enhance or suppress the translation of mRNAs into proteins.

The potential implications of SNORD114-14 as a drug target or biomarker are significant. If SNORD114-14 is successfully targeted by a drug, it could lead to the development of a new treatment for various diseases, including cancer. Additionally, if SNORD114-14 is used as a biomarker, it could be used to diagnose and monitor the effectiveness of various treatments.

In conclusion, SNORD114-14 is a non-coding RNA molecule that has unique functions and potential as a drug target or biomarker. Its ability to interact with specific protein molecules and regulate the expression of various genes makes it an intriguing target for researchers to investigate. Further studies are needed to fully understand the role of SNORD114-14 in various diseases and to develop effective treatments based on its unique properties.

Protein Name: Small Nucleolar RNA, C/D Box 114-14

The "SNORD114-14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD114-14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets